ENGLEWOOD, CO — (Marketwire) — 11/04/09 — Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer® II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation’s leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

The Demolizer® II is a safe and simple biomedical waste treatment system ideally suited to meet the unique needs of clinics in rural areas where the cost, both financial and environmental, of traditional transport and offsite disposal can be prohibitive. Cost savings from adoption of the Demolizer® II are expected to be significant. More importantly, the Demolizer® II

ENGLEWOOD, CO–(Marketwire – 10/14/09) – Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTC.BB:BMTL) is pleased to announce significant developments on the commercialization of its Demolizer(R) Home unit, a safe and environmentally friendly biomedical waste disposal device designed to enable diabetics and others using syringes at home to safely destroy their sharps waste and dispose of it in the regular trash or send it to a BMTS’ recycling partner. Through treatment in the Demolizer(R) Home unit, used syringes and lancets are sterilized and grossly melted so that they cannot be reused and no longer pose a risk of infection. BMTS’ engineers have neared conclusion of the design aspects of the device and have progressed it from conception to bench testing and are implementing the patent process.

In 2006, an estimated 8 million people in the U.S. administered 3 billion injections at home annually. Most of these contaminated

Don Cox, President and CEO of Biomedical Technology Solutions Holdings, Inc. (”BMTS” www.bmtscorp.com) (OTC.BB:BMTL) stopped by SmallCapVoice.com to dicuss how his company sells the Demolizer® II through its wholly owned subsidiary Biomedical Technology Solutions, Inc. BMTS’ patented Demolizer® Technology converts infectious biomedical waste into non-infectious material. BMTS’ products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the U.S.

BioMedical Technology Solutions Holdings, Inc., the maker of the patented Demolizer® Technology that converts infectious biomedical waste into non-infectious material, recently announced the signing of a multinational distribution partnership with Novismed Corporation for the international sale and distribution of the Demolizer II® System in Central and Latin America and the Caribbean.

The Demolizer® II System is an environmentally friendly alternative to biomedical waste disposal. The device is the only patented, portable and self-contained system able to process both sharps and typical red bag biomedical waste onsite.

Novismed Corporation, located in Miami, Florida, has established long-term seasoned partnerships with key distributors in Central America, Latin America and the Caribbean. Additionally, the company has expansive market coverage in more than 15 countries, including Mexico, Chile and Argentina.

Don Cox, president and chief executive officer of BioMedical Technology Solutions, Inc., stated, “This is an important milestone for our company and Novismed Corporation. We feel